Wego Orthopedic released its 2026 interim report. Total operating revenue was 704 million yuan, down 4.93% from the same period last year. Net profit attributable to the parent company was 132 million yuan, down 6.85% year on year. Net cash inflow from operating activities was 140 million yuan, down 24.59% year on year. The company's latest asset-liability ratio was 18.74%, gross margin was 63.57%, return on equity was 3.15%, and diluted earnings per share was 0.33 yuan. The number of shareholders was 10,100, and the top ten shareholders held 85.01% of total share capital.
Shandong Weigao Orthopaedic Device Co. Ltd. ANet profit and revenue declined year on year, with operating cash flow also down.